Shih-Che Hsu

Shih-Che Hsu

Auto-generated profile, based on publicly available information

Shih-Che Hsu

CVie Therapeutics Limited

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
LCLi-Han Chin
Li-Han Chin
YHYu-Juei Hsu
Yu-Juei Hsu
SHShih-Che Hsu
Shih-Che Hsu
YCYen-Hui Chen
Yen-Hui Chen
YCYung-Lung Chang
Yung-Lung Chang
CLChih-Yuan Lin
Chih-Yuan Lin
The regulation of NLRP3 inflammasome expression during the development of cardiac contractile dysfunction in chronic kidney disease The regulation of NLRP3 inflammasome expression during the development of cardiac contractile dysfunction in chronic kidney disease

26 January 2022 in Life
Verified
Journal Article
Open access
PDF file
HYHsiang-Yu Yang
Hsiang-Yu Yang
Jhaoying ChenJhaoying Chen
Jhaoying Chen
YHYEN-NIEN HUO
YEN-NIEN HUO
PYPei-Ling Yu
Pei-Ling Yu
PLPei-Zhen Lin
Pei-Zhen Lin
CLChih-Yuan Lin
Chih-Yuan Lin
Background: Lipotoxicity causes endoplasmic reticulum (ER) stress, leading to cell apoptosis. Sirtuin 1 (Sirt1) regulates gene transcription and cellular metabolism. In this study, we investigated the role of Sirt1 in palmitate-induced ER stress. Methods: Both H9c2 myoblasts and heart-specific Sirt1 knockout mice fed a palmitate-enriched high-fat diet were used. Results: The high-fat diet induced C/EBP homologous protein (CHOP) and activating transcription factor 4 (ATF4) expression in both Sirt1 knockout mice and controls. The Sirt1 knockout mice showed higher CHOP and ATF4 expression compared to those in the control. Palmitic acid (PA) induced ATF4 and CHOP expression in H9c2 cells. PA-treated H9c2 cells showed decreased cytosolic NAD+/NADH alongside reduced Sirt1′s activity. The H9c2 cells showed increased ATF4 and CHOP expression when transfected with plasmid encoding dominant negative mutant Sirt1. Sirt1 activator SRT1720 did not affect CHOP and ATF4 expression. Although SRT1720 enhanced the nuclear translocation of ATF4, the extent of the binding of ATF4 to the CHOP promoter did not increase in PA treated-H9c2 cells. Conclusion: PA-induced ER stress is mediated through the upregulation of ATF4 and CHOP. Cytosolic NAD+ concentration is diminished by PA-induced ER stress, leading to decreased Sirt1 activity. The Sirt1 activator SRT1720 promotes the nuclear translocation of ATF4 in PA-treated H9c2 cells.

26 January 2026 in Phytotherapy Research
Verified
Journal Article
Closed access
Gwo-Jyh ChangGwo-Jyh Chang
Gwo-Jyh Chang
YYYung-Hsin Yeh
Yung-Hsin Yeh
WCWei‐Jan Chen
Wei‐Jan Chen
SHShih‐Che Hsu
Shih‐Che Hsu
YLYing-Ju Lai
Ying-Ju Lai
HLHsiao‐Yu Lee
Hsiao‐Yu Lee

11 July 2023
Verified
Preprint
Open access
PDF file
MAMartina Arici
Martina Arici
SHShih-Che Hsu
Shih-Che Hsu
MFMara Ferrandi
Mara Ferrandi
PBPaolo Barassi
Paolo Barassi
CRCarlotta Ronchi
Carlotta Ronchi
MRMarcella Rocchetti
Marcella Rocchetti
Background and Purpose. The sarcoplasmic reticulum (SR) Ca2+ ATPase (SERCA2a) depression substantially contributes to diastolic dysfunction in heart failure (HF), suggesting that SERCA2a stimulation may be a “causal” HF therapy. Istaroxime is a drug endowed with both a SERCA2a stimulatory activity and a Na+/K+ pump inhibitory activity for the acute HF treatment. Its main metabolite PST3093 shows a more favorable therapeutic profile as compared to the parent drug, but it is still unsuitable for chronic usage. Novel PST3093 derivatives have been recently developed for oral (chronic) HF treatment; compound 8 was selected among them and here characterized. Experimental Approach. Effects of compound 8 were evaluated in a context of SERCA2a depression, by using streptozotocin-treated rats, a well-known model of diastolic dysfunction. The impact of SERCA2a stimulation by compound 8 was assessed both at the cellular level ad in vivo, following i.v. infusion (acute effects) or oral administration (chronic effects). Key Results. As expected from SERCA2a stimulation, compound 8 induced SR Ca2+ compartmentalization in STZ myocytes. In-vivo echocardiographic analysis during i.v. infusion and after repeated oral administration of compound 8, detected a significant improvement of diastolic function. Moreover, compound 8 did not affect electrical activity of healthy guinea-pig myocytes, in line with the absence of off-target effects. Finally, compound 8 was well tolerated in mice with no evidence of acute toxicity. Conclusion and Implications. The pharmacological evaluation of compound 8 indicates that it may be a safe and selective drug for a “causal” treatment of chronic HF by restoring SERCA2a activity.

17 September 2023 in ISEE Conference Abstracts
Verified
Journal Article
Closed access
SHShih-Che Hsu
Shih-Che Hsu
IHIan Hamilton
Ian Hamilton
AMAlison Moody
Alison Moody
SSShaun Scholes
Shaun Scholes
FBFeifei Bu
Feifei Bu
ASAndrew Steptoe
Andrew Steptoe

17 September 2023 in ISEE Conference Abstracts
Verified
Journal Article
Closed access
SHShih-Che Hsu
Shih-Che Hsu
KPKE-TING PAN
KE-TING PAN
Li-Ting KaoLi-Ting Kao
Li-Ting Kao
HKHarry Kennard
Harry Kennard
GHGesche Huebner
Gesche Huebner
IHIan Hamilton
Ian Hamilton